FDA Inspection 1273719 — ACS Dobfar S.P.A.
The FDA completed an inspection of ACS Dobfar S.P.A. on Oct 27, 2023 in Verona. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 27, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Verona (Italy)
Additional Details
Mutual Recognition Agreement (MRA)